Professor Helen Tremlett is a neuroepidemiologist with special interest in studies of the natural course of multiple sclerosis, studies of prognosis and predictors of disease progression efficacy and safety of immunomodulatory drugs and pharmacogenomics.
UBC in Canada has one of the largest longitudinal population-based databases in the world comprising more than 7500 patients followed for over 25 years.